Petco Health and Wellness

WOOF · NASDAQ

$2.33−$0.01 (−0.43%)TodayMarket closed · Oct 20, 5:41 PM ET

Prev close $2.34

WOOF analyst rating

HoldConsensus of 6 analysts over the last 12 months. 17% rate it a buy.

Strong buy0
Buy1
Hold4
Underperform1
Sell0

12-month price target · 13 analysts

Average $3.68 (+57.8% upside)

Low: $2.13
Now: $2.33
High: $5.25

Upgrades and downgrades

The latest rating actions, newest first

WOOF analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Evercore ISI Group	Sep 29, 2026	Maintains	In-Line	$4.00 → $3.00	66%
BNP Paribas	Sep 3, 2026	Maintains	Underperform	$2.34 → $2.11	56%
UBS	Sep 3, 2026	Maintains	Neutral	$4.00 → $3.50	70%
Baird	Sep 3, 2026	Maintains	Neutral	$3.00 → $3.25	54%
Evercore ISI Group	Sep 1, 2026	Maintains	In-Line	$3.50 → $4.00	66%
Citigroup	Jun 4, 2026	Maintains	Neutral	$4.00 → $3.25	44%
Evercore ISI Group	Jun 4, 2026	Maintains	In-Line	$3.00 → $3.50	66%
UBS	Mar 16, 2026	Maintains	Neutral	$3.50 → $4.00	70%
Citigroup	Mar 16, 2026	Maintains	Neutral	$3.50 → $4.00	44%
Jefferies	Mar 12, 2026	Upgrade	Hold → Buy	$4.05 → $5.00	45%

The case for and against

Updated Feb 9, 2026

Bull case

Petco Health and Wellness Co Inc has demonstrated a positive financial trajectory, particularly evidenced by an expansion of gross margin by approximately 120 basis points year-over-year, surpassing forecasts due to improved performance in both product and service categories. The company's strategic moves, such as closing unprofitable stores and enhancing vendor partnerships, have allowed it to slightly elevate its full-year adjusted EBITDA guidance, reflecting effective operational momentum despite tariff-related challenges. Additionally, the combination of improved inventory management and pricing optimization has contributed to EBITDA margin expansion in the first half of the year, reinforcing the company's position for future growth as market dynamics evolve.

Bear case

Petco Health and Wellness has experienced a concerning decline in net sales, down 2.3% year-over-year, including a 1.6% decrease in comparable sales, indicating a potential continued loss of market share. The company's guidance for net sales in 3Q 2025 suggests low-single digit declines, alongside pressures from margin challenges and difficulties in expanding its veterinary operations due to staffing issues. Additionally, the shift of consumer purchasing toward e-commerce primarily for commoditized products, such as pet food, has contributed to Petco losing market share to more agile online competitors.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.